Platinum Investment Management’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-739,342
Closed -$1.38M 116
2025
Q1
$1.38M Sell
739,342
-212,727
-22% -$536K 0.08% 61
2024
Q4
$2.57M Hold
952,069
0.15% 56
2024
Q3
$3.6M Hold
952,069
0.16% 49
2024
Q2
$3.8M Sell
952,069
-142,957
-13% -$473K 0.15% 46
2024
Q1
$3.24M Sell
1,095,026
-420,559
-28% -$1.51M 0.13% 55
2023
Q4
$7.58M Buy
1,515,585
+193,123
+15% +$621K 0.31% 46
2023
Q3
$3.77M Hold
1,322,462
0.15% 56
2023
Q2
$3.91M Buy
1,322,462
+240,000
+22% +$524K 0.14% 63
2023
Q1
$2.53M Hold
1,082,462
0.09% 76
2022
Q4
$2.21M Buy
1,082,462
+23,000
+2% +$59.3K 0.08% 76
2022
Q3
$3.35M Hold
1,059,462
0.14% 59
2022
Q2
$3.83M Sell
1,059,462
-3,000
-0.3% -$10.3K 0.14% 58
2022
Q1
$4.25M Hold
1,062,462
0.13% 60
2021
Q4
$5.26M Hold
1,062,462
0.15% 60
2021
Q3
$7.13M Buy
1,062,462
+634,926
+149% +$4.55M 0.2% 52
2021
Q2
$3.39M Buy
+427,536
New +$2.95M 0.08% 77

Other funds holding ACIU

Platinum Investment Management's ACIU Position: Q2 2025 in Review

Platinum Investment Management sold out of AC Immune (ACIU) in Q2 2025, closing a stake of 739,342 shares — an estimated $1.38M sold.

Platinum Investment Management first reported a position in ACIU in Q2 2021 and held it in 16 quarters. The position peaked at $7.58M in Q4 2023. 42 funds tracked by Wall St. Rank hold ACIU as of Q2 2025.

  • Platinum Investment Management reported no remaining AC Immune position as of Q2 2025 after selling out during the quarter.
  • Platinum Investment Management sold 739,342 AC Immune shares in Q2 2025, an estimated $1.38M.
  • Platinum Investment Management first reported a position in AC Immune in Q2 2021 and held it in 16 quarters.
  • Platinum Investment Management's AC Immune position peaked at $7.58M in Q4 2023.
  • 42 funds tracked by Wall St. Rank held AC Immune as of Q2 2025.

Based on Platinum Investment Management's 13F filing for Q2 2025, filed 21 Jul 2025.